B Group, Inc.

CIK

2043476

Location

DALLAS, TX

Portfolio Value

Small $134,887,408

Diversification

Diversified

Filing Date

Global Rank

#5,082 / 8,622 ▲ 146 · as of Mar 2026

Top Industry

Biotechnology 97.3%

3Y Alpha vs SPY

+7.7%

Period ended 4 months ago

Filed May 15, 2026 · 2mo

6 quarters · since Dec 2024

Clone Performance

Feb 2025–Jul 2026 · vs SPY

Hypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.

Cloned portfolio

+32.6%

SPY

+23.3%

Annualised alpha

+5.9%

Max drawdown

−32.8%

Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 96% of reported value on average across 6 quarters. Past performance does not predict future results.

Portfolio Concentration

20 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025

Top Position

21.4%

−11.7 pts

Top 5

58.2%

−9.0 pts

Top 10

81.1%

−8.8 pts

HHI

1,003

Diversified−523

Portfolio Trend

6 quarters · across all stocks

Sector Breakdown

As of Mar 31, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$134,887,408	20

Last Quarter's Activity

Export CSV

Mar 31, 2026 vs Dec 31, 2025

Added To

Positions the filer increased

6 positions

Ticker	Company	Δ Shares	Shares	Value
PALI	Palisade Bio, Inc.	+6,914,285	11,414,285	$19,974,998
ADMA	Adma Biologics, Inc.	+750,000	3,207,542	$28,899,953
ZLAB	Zai Lab Ltd	+50,646	450,646	$8,476,651
SGHT	Sight Sciences, Inc.	+50,000	970,000	$3,656,900
GPCR	Structure Therapeutics Inc.	+37,500	127,500	$6,145,500
AURA	Aura Biosciences, Inc.	+25,000	597,576	$3,997,783
No positions match the current search.

Trimmed

Positions the filer reduced

2 positions

Ticker	Company	Δ Shares	Shares	Value
REPL	Replimune Group, Inc.	−24,000	26,000	$198,900
APGE	Apogee Therapeutics, Inc.	−12,500	7,500	$631,275
No positions match the current search.

New Positions

Positions the filer opened this quarter

4 positions

Ticker	Company	Shares	Value
NRXP	NRX Pharmaceuticals, Inc.	3,000,000	$6,390,000
DRUG	Bright Minds Biosciences Inc.	67,500	$4,925,475
FHTX	Foghorn Therapeutics Inc.	102,000	$487,560
SLNO	Soleno Therapeutics Inc	7,500	$251,100
No positions match the current search.

Sold Out

Positions the filer fully exited

No qualifying positions this quarter.

Portfolio Positions

Compact Export CSV View 13F filing

20 tracked positions · $134,887,408 total · as of Mar 31, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
ADMA	Adma Biologics, Inc. Healthcare	Added	3,207,542	+750,000	$28,899,953	−35.5%	21.43%
PALI	Palisade Bio, Inc. Healthcare	Added	11,414,285	+6,914,285	$19,974,998	+88.9%	14.81%
PRAX	Praxis Precision Medicines, Inc. Healthcare	Held	33,237	0	$10,708,629	+9.3%	7.94%
CLLS	Cellectis S.A. Healthcare	Held	3,281,501	0	$10,402,358	−34.5%	7.71%
ZLAB	Zai Lab Ltd Healthcare	Added	450,646	+50,646	$8,476,651	+20.1%	6.28%
TSHA	Taysha Gene Therapies, Inc. Healthcare	Held	1,800,556	0	$8,048,485	−18.7%	5.97%
NRXP	NRX Pharmaceuticals, Inc. Healthcare	NEW	3,000,000	NEW	$6,390,000	NEW	4.74%
GPCR	Structure Therapeutics Inc. Healthcare	Added	127,500	+37,500	$6,145,500	−1.8%	4.56%
IOVA	Iovance Biotherapeutics, Inc. Healthcare	Held	1,500,000	0	$5,265,000	+28.6%	3.90%
SYRE	Spyre Therapeutics, Inc. Healthcare	Held	100,000	0	$5,044,000	+54.0%	3.74%
DRUG	Bright Minds Biosciences Inc. Healthcare	NEW	67,500	NEW	$4,925,475	NEW	3.65%
ASMB	Assembly Biosciences, Inc. Healthcare	Held	175,706	0	$4,875,841	−18.4%	3.61%
AURA	Aura Biosciences, Inc. Healthcare	Added	597,576	+25,000	$3,997,783	+28.1%	2.96%
ORKA	Oruka Therapeutics, Inc. Healthcare	Held	75,000	0	$3,678,750	+61.8%	2.73%
SGHT	Sight Sciences, Inc. Healthcare	Added	970,000	+50,000	$3,656,900	−49.9%	2.71%
RARE	Ultragenyx Pharmaceutical Inc. Healthcare	Held	135,000	0	$2,828,250	−8.9%	2.10%
APGE	Apogee Therapeutics, Inc. Healthcare	Reduced	7,500	-12,500	$631,275	−58.2%	0.47%
FHTX	Foghorn Therapeutics Inc. Healthcare	NEW	102,000	NEW	$487,560	NEW	0.36%
SLNO	Soleno Therapeutics Inc Healthcare	NEW	7,500	NEW	$251,100	NEW	0.19%
REPL	Replimune Group, Inc. Healthcare	Reduced	26,000	-24,000	$198,900	−59.1%	0.15%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.